Diogjena Katerina Prifti
Centre Hospitalier de l’Université de Montréal(CA)
Publications by Year
Research Areas
Microtubule and mitosis dynamics, Gut microbiota and health, Cellular Mechanics and Interactions, Clostridium difficile and Clostridium perfringens research, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Recent Progress on the Localization of the Spindle Assembly Checkpoint Machinery to Kinetochores(2019)39 cited
- → A quantitative and semiautomated method for determining misaligned and lagging chromosomes during mitosis(2020)8 cited
- → Abstract 2210: Microbiome profiling reveals that fecal microbiota transplantation (FMT) modulates response and toxicity when combined with immunotherapy in patients with lung cancer and melanoma (FMT-LUMINate NCT04951583)(2025)6 cited
- → Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial(2026)5 cited
- → ARHGEF17/TEM4 regulates the cell cycle through control of G1 progression(2024)3 cited
- → A commercial ARHGEF17/TEM4 antibody cross-reacts with Nuclear Mitotic Apparatus protein 1 (NuMA)(2022)3 cited
- → An unbiased, quantitative and versatile method for determining misaligned and lagging chromosome during mitosis(2020)2 cited
- → Abstract 2223: Phase I clinical trial combining camu camu prebiotic enriched with castalagin modulates bile acids and metabolites in combination with cancer immunotherapy in patients with treatment-naïve lung cancer and PD-1 refractory melanoma (NCT05303493)(2025)1 cited
- → LBA62 Phase I trial of camu camu prebiotic plus immunotherapy in patients with melanoma and non-small cell lung cancer (NSCLC)(2025)
- → Abstract C065: Impact of polyethylene glycol bowel preparation on the gut microbiome composition and response to immune checkpoint inhibition(2026)